Invention Grant
- Patent Title: Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors
-
Application No.: US15146874Application Date: 2016-05-04
-
Publication No.: US10231974B2Publication Date: 2019-03-19
- Inventor: Julio César Villamil Torres , Camilo Rey Ferro
- Applicant: Companion Supplements, LLC
- Applicant Address: US FL Sunrise
- Assignee: Companion Therapeutics, LLC
- Current Assignee: Companion Therapeutics, LLC
- Current Assignee Address: US FL Sunrise
- Agency: The Morales Law Firm, LLC
- Agent Joseph L. Morales
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K31/519 ; A61K9/00 ; A61K9/48 ; A61K31/198 ; A61K31/525 ; A61K31/675 ; A61K31/714 ; A61K36/28
Abstract:
The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.
Public/Granted literature
Information query
